Acadia Healthcare Company Inc. (NASDAQ: ACHC) saw its stock price surge 11.24% in pre-market trading on Wednesday. The significant move followed the release of the behavioral healthcare provider's fourth-quarter and full-year 2025 financial results.

The stock's sharp rise was driven by the company reporting quarterly earnings and sales that exceeded analyst expectations. Acadia Healthcare posted adjusted earnings per share of $0.07 for Q4 2025, beating the consensus estimate of $0.06 by 20.69%. Quarterly revenue reached $821.459 million, surpassing the $800.065 million estimate by 2.67% and representing a 6.1% increase over the same period last year.

While the company reported a substantial net loss attributable to shareholders of $1.178 billion for the quarter, this was primarily due to a non-cash goodwill impairment charge of $996.2 million. Excluding this and other one-time items, adjusted net income was $6.1 million. The company also provided guidance for the first quarter and full fiscal year 2026, outlining its operational priorities and development plans.